Sertraline and Visual Snow Syndrome
Based on emerging evidence, sertraline can trigger visual snow syndrome (VSS), and this condition may persist or even worsen after discontinuing the medication.
Evidence for Causation
The most recent and direct evidence comes from a 2025 systematic analysis of 24 cases linking serotonin reuptake inhibiting antidepressants, including sertraline, to visual snow syndrome 1. This study found:
- Visual snow symptoms began while on the drug in 58% of cases, after dose reduction in 25%, and after discontinuation in 17% 1
- 92% of patients had stopped the suspect drug but experienced no resolution of symptoms 1
- The mean causality score (RxISK) was 9.5 out of 17, indicating a strong possibility of a drug-medication link 1
- 42% of patients developed full visual snow syndrome (not just isolated visual snow) 1
Contradictory Evidence
Importantly, one older systematic review from 2020 listed sertraline among medications that were "effective at least once" in treating VSS symptoms 2. However, this finding was based on anecdotal case reports and should not outweigh the more recent, systematic evidence demonstrating sertraline as a trigger rather than a treatment 1.
A 2024 review explicitly noted that "certain antidepressants" can worsen or trigger visual symptoms in VSS 3, supporting the more recent causation evidence.
Clinical Implications
If a patient on sertraline develops visual snow syndrome, the medication should be discontinued with appropriate tapering 1. However, clinicians must counsel patients that:
- Symptoms may not resolve after stopping sertraline 1
- Symptoms can emerge or worsen during dose reduction or after complete discontinuation 1
- This represents a potentially persistent adverse effect that requires close monitoring 1
Mechanism and Context
The pathophysiology likely involves cortical hyperresponsivity in visual brain areas and alterations in serotoninergic neurotransmission 3. VSS is increasingly understood as a network disorder affecting multiple cortical and thalamic regions 3.
Common Pitfalls
- Do not assume visual symptoms will resolve simply by stopping sertraline—the condition can be persistent or even worsen after discontinuation 1
- Do not dismiss patient reports of "TV static" vision as psychosomatic—this is a recognized neurological syndrome with objective findings on electrophysiological studies 3
- Do not confuse VSS with migraine aura—VSS is continuous and persistent (>3 months), whereas migraine aura is episodic 4